Nuwellis (NUWE) Cash from Operations Growth (5y) (2016 - 2026)
Nuwellis (NUWE) Cash from Operations Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn |
| 10 | Nuwellis | 203,082.78 | -3.72 Mn | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.63% |
| Mar 31, 2026 | 10.38% |
| Dec 31, 2025 | 2.33% |
| Sep 30, 2025 | 6.50% |
| Jun 30, 2025 | 8.47% |
| Mar 31, 2025 | 14.33% |
| Dec 31, 2024 | 17.89% |
| Sep 30, 2024 | 6.53% |
| Jun 30, 2024 | 7.04% |
| Mar 31, 2024 | 10.22% |
| Dec 31, 2023 | -0.27% |
| Sep 30, 2023 | -2.60% |
| Jun 30, 2023 | -8.82% |
| Mar 31, 2023 | -3.93% |
| Dec 31, 2022 | 0.15% |
| Sep 30, 2022 | -1.18% |
| Jun 30, 2022 | 0.73% |
| Mar 31, 2022 | -24.50% |
| Dec 31, 2021 | -8.77% |
| Sep 30, 2021 | -0.27% |